Nd:YAG Laser (1064 nm): uses, dark-skin safety, and expectations

The Nd:YAG laser — neodymium-doped yttrium aluminum garnet — emits light at 1064 nanometers, the longest wavelength commonly used in aesthetic dermatology. That single property explains most of what makes it unique: 1064 nm penetrates deeper into tissue than any other aesthetic laser wavelength, has lower melanin absorption at the epidermal level than shorter wavelengths, and can target hemoglobin, melanin, and water depending on pulse duration and fluence.

This guide covers how the Nd:YAG laser works, which indications the FDA has cleared, why it is the default wavelength for darker skin, and what patients should expect from treatment.

How the Nd:YAG laser works

The Nd:YAG crystal produces a 1064 nm wavelength in the near-infrared spectrum. At this wavelength:

• Melanin absorption is lower than at shorter wavelengths (alexandrite at 755 nm, diode at 810 nm). This means the epidermis — which contains melanin, especially in darker skin tones — absorbs less energy, reducing the risk of burns, blistering, and post-inflammatory hyperpigmentation.
• Hemoglobin absorption is meaningful but moderate. At 1064 nm, the laser can target oxyhemoglobin and deoxyhemoglobin in blood vessels, making it effective for vascular lesions, diffuse redness, and certain types of leg veins.
• Water absorption is low. Unlike CO₂ (10,600 nm) or Er:YAG (2,940 nm) lasers, Nd:YAG does not primarily target water. However, long-pulse Nd:YAG can generate sufficient tissue heating for collagen stimulation and mild skin tightening effects.
• Depth of penetration is the deepest among aesthetic laser wavelengths. At 1064 nm, the beam reaches several millimeters into the dermis, enabling treatment of deeper targets — deep hair follicles, reticular veins, and dermal pigment.

The chromophore target can be shifted by changing the pulse duration and fluence:

The same 1064 nm wavelength serves fundamentally different clinical purposes depending on how the energy is delivered.

FDA-cleared indications

Multiple Nd:YAG laser devices have received FDA 510(k) clearance for aesthetic and dermatologic use. The cleared indications vary by device but commonly include:

• Hair removal — permanent hair reduction across all skin types, including Fitzpatrick IV–VI
• Vascular lesions — telangiectasia, spider veins, hemangiomas, venous lakes, leg veins up to approximately 3 mm diameter
• Pigmented lesions — lentigines, freckles, café-au-lait macules, Nevus of Ota, dermal melanosis
• Wrinkle reduction — non-ablative skin rejuvenation and collagen stimulation
• Tattoo removal — Q-switched and picosecond modes for multicolor tattoo ink
• Onychomycosis — nail fungus treatment (Candela GentleYAG cleared for this indication)
• Pseudofolliculitis barbae — razor bumps, particularly in skin of color

Common FDA-cleared Nd:YAG devices include the Candela GentleYAG Pro, Cutera excel HR (combined Nd:YAG + diode), Cynosure Elite MPX (combined alexandrite + Nd:YAG), Fotona SP Dynamis, and Lutronic Spectra.

Nd:YAG for hair removal

Nd:YAG is the safest laser wavelength for hair removal in patients with Fitzpatrick skin types IV–VI — medium-dark to dark skin. This is not a preference; it reflects the physics of how 1064 nm interacts with melanin.

Why 1064 nm is safer for darker skin

Shorter wavelengths (alexandrite at 755 nm, IPL at 500–1200 nm) are strongly absorbed by melanin. In patients with more epidermal melanin, the energy is absorbed at the skin surface before it can reach the hair follicle. This causes epidermal heating, which can produce burns, blistering, and post-inflammatory hyperpigmentation — the exact complications patients are trying to avoid.

At 1064 nm, melanin absorption is significantly lower. More energy passes through the epidermis to reach the deeper hair follicle, where it is absorbed by melanin in the hair shaft and bulb. The epidermis is spared because it absorbs less of the total energy.

This safety advantage is well-established in the literature. The American Academy of Dermatology and the American Society for Dermatologic Surgery both identify Nd:YAG as the recommended wavelength for hair removal in patients with darker skin tones.

Treatment parameters

• Sessions needed: Typically 6–8 sessions for Fitzpatrick I–III, and 8–10 sessions for Fitzpatrick IV–VI where lower fluences must be used, spaced 4–8 weeks apart depending on the body area
• Effectiveness: 70–85% permanent hair reduction after a full course of treatment in ideal candidates (dark hair, lighter skin). Results are slightly less dramatic in patients with very dark skin because lower fluences must be used to maintain safety.
• Discomfort: Nd:YAG can be more uncomfortable than alexandrite or diode because the longer wavelength requires higher fluence to achieve sufficient follicular damage. Most patients describe a rubber-band-snapping sensation. Integrated cooling (contact cooling, cryogen spray) is standard on modern devices.

Nd:YAG vs other hair removal wavelengths

For a comprehensive comparison of laser hair removal wavelengths, see our laser hair removal guide.

Nd:YAG for vascular lesions

Long-pulse Nd:YAG is one of the most versatile vascular lasers available. It can treat vessels from fine telangiectasia to reticular veins up to approximately 3 mm in diameter.

• How it works: The 1064 nm wavelength is absorbed by hemoglobin in blood vessels. The energy heats the vessel wall, causing thermocoagulation and vessel closure. Over weeks to months, the body clears the treated vessel.
• What it treats: Facial telangiectasia (spider veins), perinasal veins, leg veins (spider and small reticular), cherry angiomas, venous lakes, and some hemangiomas.
• Depth advantage: The deep penetration of 1064 nm allows treatment of vessels located deeper in the dermis than PDL (585–595 nm) or KTP (532 nm) can reach. This is particularly relevant for perinasal and leg veins that sit below the superficial dermal plexus.
• Fitzpatrick safety: Unlike shorter-wavelength vascular lasers (PDL, KTP, IPL), Nd:YAG can treat vascular lesions in Fitzpatrick IV–VI with lower PIH risk, for the same reason it is safer for hair removal — lower melanin absorption at the epidermal level.

For comparison with other vascular laser options, see our guides on PDL/Vbeam vs Excel V and the best laser for rosacea.

Nd:YAG for pigmented lesions and melasma

Q-switched and picosecond Nd:YAG lasers are used to treat unwanted pigment — lentigines, café-au-lait macules, dermal melanosis, and certain types of melasma.

The melasma question

Melasma treatment with any laser is controversial. Melasma is a chronic condition driven by melanocyte hyperactivity, often triggered by hormones and UV exposure. Laser treatment can improve melasma in the short term, but rebound hyperpigmentation is a well-documented risk — the pigment returns, sometimes worse than before.

Q-switched Nd:YAG at low fluence (sometimes called "laser toning") has been used for melasma treatment, particularly in East Asian populations. However, multiple studies have raised concerns about:

• Rebound melasma after treatment series end
• Paradoxical hyperpigmentation from subclinical thermal injury to melanocytes
• Mottled depigmentation from repeated low-fluence treatments over time

The evidence is mixed enough that Nd:YAG should not be presented as a first-line melasma treatment. Topical therapy (hydroquinone, azelaic acid, tranexamic acid), strict sun protection, and a structured treatment ladder — as outlined in our melasma treatment ladder guide — remain the standard of care before device-based treatment is considered.

For Fitzpatrick IV–VI patients specifically, any pigment-targeting laser carries PIH risk. The Nd:YAG's lower melanin absorption reduces this risk compared to shorter wavelengths, but does not eliminate it.

Nd:YAG for skin tightening

Long-pulse Nd:YAG generates controlled thermal injury in the dermis, triggering a wound-healing response that stimulates new collagen production. This is sometimes called "non-ablative skin rejuvenation" or "laser skin tightening."

• What it can do: Mild improvement in skin firmness, fine lines, and texture. The effect is gradual (developing over weeks to months) and modest compared to RF microneedling, fractional lasers, or surgical lifting.
• What it cannot do: Produce the degree of tightening that Ultherapy, Morpheus8, or a facelift can achieve. Nd:YAG skin tightening is best understood as a gentle collagen-stimulating treatment for patients who want improvement without downtime, not as an alternative to more effective tightening modalities.
• Sessions: Typically 3–6 sessions spaced 2–4 weeks apart for cumulative collagen building.

For a comprehensive comparison of non-surgical tightening options, see our guide on non-surgical facelift devices.

Cost by indication

Costs vary by geography, provider, and device. These ranges reflect 2026 U.S. averages.

Hair removal packages — where a practice bundles all sessions upfront at a discount — are common and can reduce per-session cost by 15–20%.

Safety and adverse effects

Nd:YAG is one of the safest aesthetic laser wavelengths, but it is not risk-free. Common and potential adverse effects include:

Common (temporary):

• Erythema (redness) lasting minutes to hours
• Mild edema (swelling), especially after vascular treatment
• Discomfort during treatment (managed with cooling)

Less common:

• Blistering — from excessive fluence or inadequate cooling, especially in darker skin
• Post-inflammatory hyperpigmentation — lower risk than shorter wavelengths but not zero, particularly after pigment-targeting treatment in Fitzpatrick IV–VI
• Hypopigmentation — from overtreatment, particularly with Q-switched modes
• Purpura (bruising) — with vascular treatment at higher fluences

Contraindications:

• Active infection in the treatment area (herpes simplex, bacterial skin infection)
• Isotretinoin use within the past 6–12 months (increased scarring risk)
• Pregnancy (precautionary — most providers defer elective laser treatment)
• History of keloid or hypertrophic scarring (relative contraindication; requires caution)
• Photosensitizing medications (requires evaluation on a case-by-case basis)

Fitzpatrick-specific considerations:

• Fitzpatrick I–III: Nd:YAG is safe and effective for all indications. Lower fluences are used than for darker skin because the epidermal melanin "competition" is minimal.
• Fitzpatrick IV–VI: Nd:YAG is the recommended wavelength for hair removal and vascular treatment. Fluences should be lower, cooling should be aggressive, and test spots may be performed before full treatment. The PIH risk is low relative to other wavelengths but is not zero — patients should be informed and should verify that their provider has experience treating darker skin with Nd:YAG.

For a broader discussion of energy device safety in darker skin, see our guide on skin of color safety protocols for energy devices.

Choosing a provider

The wavelength is important, but the provider determines the outcome. Questions to ask:

1. What device are you using? Confirm it is a genuine Nd:YAG laser (1064 nm), not IPL or a different wavelength. The device name should be stated explicitly (GentleYAG, excel HR, Spectra, etc.).
2. How many Nd:YAG treatments have you performed on my skin type? Experience with your Fitzpatrick type is critical — particularly for Fitzpatrick IV–VI, where fluence selection and cooling management directly affect safety.
3. Do you perform test spots? For darker skin, a test spot on a small area 24–48 hours before full treatment is a reasonable safety measure. Not every provider does this routinely, but it is a reasonable request.
4. What fluence and cooling settings do you plan to use? You do not need to understand the numbers, but a provider who can explain their settings and reasoning has thought about your treatment rather than using a one-size protocol.
5. What is the plan if I develop PIH? Post-inflammatory hyperpigmentation is a known risk for any laser in darker skin. A prepared provider has a management plan — typically topical agents (hydroquinone, azelaic acid, or tranexamic acid) and strict sun protection.

Sources

• American Academy of Dermatology, "Laser Hair Removal: What to Know Before You Go." aad.org/public/everyday-care/skin-care-secrets/anti-aging/laser-hair-removal-safe
• FDA 510(k) Premarket Notification, Candela GentleYAG Pro (K050660). accessdata.fda.gov/cdrh_docs/pdf5/K050660.pdf
• FDA 510(k) Premarket Notification, Cutera excel HR. accessdata.fda.gov/cdrh_docs/pdf19/K190462.pdf
• American Society for Dermatologic Surgery, Laser and Light Treatment Information. asds.net/skin-experts/skin-treatments
• Lanigan SW. "Laser treatment of vascular and pigmented lesions in skin of colour." Journal of Cosmetic Dermatology (2005) 4(2):90–95.
• Battle EF. "Treatment of pigmented lesions in skin of color." Dermatologic Therapy (2011) 24(2):197–203.
• Vachiramon V et al. "Nd:YAG laser for treatment of melasma in Asians: a review of the literature." Journal of Cosmetic Dermatology (2017) 16(4):472–479.